Industry Reports
Indian biosimilar market to be worth $40 billion by 2030
The Confederation of Indian Industry (CII) & Sathguru Management Consultants released a position paper on Indian Biosimilars Industry. “Indian Biosimilars Industry:...
Articles
Change and innovation in the pharma supply chain: more of the same in 2019?
2018 has seen some of the most fundamental changes to the pharmaceutical industry– driven by serialisation requirements in the US and EU, as there...
Articles
Transforming The Life Sciences Supply Chain Through Blockchain
Imagine the Possibilities: What if innovations in the life sciences supply chain kept up with innovations in medicines and treatments?
With many serialization and track...
Articles
The need of innovation in the injectable business – a CDMO perspective
The world of drug development and manufacturing is undergoing a change. Nowhere is this more evident than in the rapid increase in complex compounds...
Articles
The importance of biometric functions to improving data quality in Clinical Trials
Reducing the costs associated with clinical trials is one of the pharmaceutical industry’s core challenges. Running a clinical trial is incredibly expensive and if...
Articles
Speed, Quality and Cost – Leveraging Australia to Expedite Clinical Development
In recent years, the pharmaceutical industry has seen tremendous changes in the way it is expected to deliver new drugs to market: being under...
Articles
Capitalizing on Digital Innovation to Enhance Delivery
The 3 Ways Johnson & Johnson Is Capitalizing on Digital Innovation to Better Deliver Medicine to You?
Janssen Supply Chain Vice President Remo Colarusso explains...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read